These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11140927)

  • 21. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are the atypical antipsychotic drugs antidepressants?
    Parker G; Malhi G
    J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
    [No Abstract]   [Full Text] [Related]  

  • 23. Olanzapine and pregnancy.
    Mendhekar DN; War L; Sharma JB; Jiloha RC
    Pharmacopsychiatry; 2002 May; 35(3):122-3. PubMed ID: 12107859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
    Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
    Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine: a novel atypical neuroleptic agent.
    Reus VI
    Lancet; 1997 May; 349(9061):1264-5. PubMed ID: 9142055
    [No Abstract]   [Full Text] [Related]  

  • 26. An open trial of olanzapine in the treatment of patients with psychotic depression.
    Nelson EB; Rielage E; Welge JA; Keck PE
    Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early relapse of psychotic symptoms after an initial response to olanzapine.
    Kostakoğlu AE; Rezaki M; Göğüş A
    Acta Psychiatr Scand; 1999 Oct; 100(4):312-4; discussion 314-5. PubMed ID: 10510702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.
    Madhusoodanan S; Brenner R; Suresh P; Concepcion NM; Florita CD; Menon G; Kaur A; Nunez G; Reddy H
    Ann Clin Psychiatry; 2000 Mar; 12(1):11-8. PubMed ID: 10798821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The psychosis of schizophrenia: prevalence, response to atypical antipsychotics, and prediction of outcome.
    Breier A; Berg PH
    Biol Psychiatry; 1999 Aug; 46(3):361-4. PubMed ID: 10435201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V; Bruxner G
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine: a new typical antipsychotic drug.
    Meltzer HY; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530
    [No Abstract]   [Full Text] [Related]  

  • 32. Esotropia associated with olanzapine.
    Singh HK; Markowitz GD; Myers G
    J Clin Psychopharmacol; 2000 Aug; 20(4):488. PubMed ID: 10917412
    [No Abstract]   [Full Text] [Related]  

  • 33. Antipsychotic drug choices now include olanzapine.
    Am J Health Syst Pharm; 1996 Dec; 53(23):2784. PubMed ID: 8957340
    [No Abstract]   [Full Text] [Related]  

  • 34. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 35. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 36. Olanzapine use in the elderly: a retrospective analysis.
    Solomons K; Geiger O
    Can J Psychiatry; 2000 Mar; 45(2):151-5. PubMed ID: 10742874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.